Compare · CGC vs TRLV
CGC vs TRLV
Side-by-side comparison of Canopy Growth Corporation (CGC) and Trulieve Cannabis Corp. Subordinate Voting Shares (TRLV): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CGC and TRLV operate in Medicinal Chemicals and Botanical Products (Health Care), so they compete in similar markets.
- TRLV is the larger of the two at $1.67B, about 9.1x CGC ($183.7M).
- TRLV has been more active in the news (8 items in the past 4 weeks vs 3 for CGC).
- CGC has more recent analyst coverage (19 ratings vs 0 for TRLV).
- Company
- Canopy Growth Corporation
- Trulieve Cannabis Corp. Subordinate Voting Shares
- Price
- -
- -
- Market cap
- $183.7M
- $1.67B
- 1M return
- -35.03%
- -
- 1Y return
- -62.27%
- -
- Industry
- Medicinal Chemicals and Botanical Products
- Medicinal Chemicals and Botanical Products
- Exchange
- NASDAQ
- NYSE
- IPO
- News (4w)
- 3
- 8
- Recent ratings
- 19
- 0
Canopy Growth Corporation
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include dried cannabis flowers, oils and concentrates, and softgel capsules. It offers its products under the Tweed, Quatreau, Deep Space, Spectrum Therapeutics, First & Free, TWD, This Works, BioSteel, DNA Genetics CraftGrow, Tokyo Smoke, DOJA, Van der Pop, and Bean & Bud brands. The company also provides growth capital and a strategic support platform that pursues investment opportunities in the global cannabis sector. Canopy Growth Corporation has a clinical research partnership with NEEKA Health Canada and NHL Alumni Association to examine the efficacy of CBD-based therapies as part of the mitigation of persistent post-concussion symptoms. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.
Trulieve Cannabis Corp. Subordinate Voting Shares
Trulieve is an industry leading, vertically integrated cannabis company and multi-state operator in the U.S., with established medical marijuana operations in Florida, Georgia, Pennsylvania, and West Virginia. Driven by a core mission to expand access to cannabis, Trulieve serves customers with innovative, high-quality branded products and exceptional experiences. With scaled operations in attractive markets and targeted expansion through its hub strategy, Trulieve is poised for accelerated growth.
Latest CGC
- Canopy Growth Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Canopy Growth Reports Second Quarter Fiscal Year 2027 Financial Results; Net Revenue Growth of 22% Led by a 141% Increase in International Markets Cannabis
- SEC Form 10-Q filed by Canopy Growth Corporation
- Canopy Growth Announces Results of 2026 Annual General and Special Meeting of Shareholders
- SEC Form 8-K filed by Canopy Growth Corporation
- Canopy Growth to Report Second Quarter Fiscal 2027 Financial Results on November 6, 2026
- SEC Form DEFA14A filed by Canopy Growth Corporation
- SEC Form 8-K filed by Canopy Growth Corporation
- Canopy Growth’s Smiths Falls Facility Becomes Canada’s Only EU GMP-Certified Site Combining Softgel Manufacturing With Primary Packaging of Softgels, Oral Liquids and Dried Cannabis Flower
- SEC Form DEFA14A filed by Canopy Growth Corporation
Latest TRLV
- Trulieve to Open Medical Cannabis Dispensary in Tampa, Florida
- Trulieve Announces Preliminary Addition to the Russell 2000® and 3000® Indices
- Trulieve Announces November 2026 Event Participation
- Trulieve Expands Medical Cannabis Access through Riverside Pharmacy in Gainesville, Georgia
- SEC Form 10-Q filed by Trulieve Cannabis Corp. Subordinate Voting Shares
- Trulieve Cannabis Corp. Subordinate Voting Shares filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
- Trulieve Reports Third Quarter 2026 Results
- Trulieve Receives DEA Registrations for State-Licensed Medical Marijuana Operations